DrugPatentWatch Database Updates: New Patent Additions
✉ Email this page to a colleague
DrugPatentWatch Database Updates: New Patent Additions
| Applicant | Tradename | Generic Name | Dosage | NDA | Number | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Requested | Patent Expiration | Date Submitted | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertical Pharms | DSUVIA | sufentanil citrate | TABLET | 209128 | 001 | Nov 2, 2018 | RX | Yes | ⤷ Sign Up | Y | ⤷ Sign Up | 2024-07-31 | ||||
| Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE | 202057 | 001 | Jul 26, 2012 | RX | Yes | ⤷ Sign Up | ⤷ Sign Up | 2017-06-26 | U-1287 | METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA | |||
| Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE | 202057 | 002 | Feb 16, 2017 | RX | Yes | ⤷ Sign Up | ⤷ Sign Up | 2017-06-26 | U-1287 | METHOD OF REDUCING TG LEVELS IN PATIENT SUFFERING FROM SEVERE HYPERTRIGLYCERIDEMIA | |||
| Melinta | BAXDELA | delafloxacin meglumine | POWDER | 208611 | 001 | Jun 19, 2017 | RX | Yes | ⤷ Sign Up | ⤷ Sign Up | 2024-07-30 | U-3967 | TREATING AN ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTION (ABSSSI) IN AN OVERWEIGHT OR OBESE PATIENT BY INTRAVENOUSLY (IV) ADMINISTERING 300MG OF DELAFLOXACIN OR A PHARMACEUTICALLY ACCEPTABLE SALT, TWICE A DAY | |||
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE | 208623 | 001 | Aug 10, 2018 | RX | Yes | ⤷ Sign Up | Y | ⤷ Sign Up | 2024-07-30 | ||||
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE | 208623 | 001 | Aug 10, 2018 | RX | Yes | ⤷ Sign Up | Y | ⤷ Sign Up | 2024-07-30 | U-2371 | THE TREATMENT OF FABRY PATIENTS | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Number | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Requested | >Patent Expiration | >Date Submitted | >Usecode | >Patented / Exclusive Use |
